IBDEI0WV ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16292,1,3,0)
 ;;=3^389.9
 ;;^UTILITY(U,$J,358.3,16292,1,4,0)
 ;;=4^HEARING LOSS
 ;;^UTILITY(U,$J,358.3,16292,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,16293,0)
 ;;=380.4^^105^1016^8
 ;;^UTILITY(U,$J,358.3,16293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16293,1,3,0)
 ;;=3^380.4
 ;;^UTILITY(U,$J,358.3,16293,1,4,0)
 ;;=4^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,16293,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,16294,0)
 ;;=382.9^^105^1016^9
 ;;^UTILITY(U,$J,358.3,16294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16294,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,16294,1,4,0)
 ;;=4^OTITIS MEDIA
 ;;^UTILITY(U,$J,358.3,16294,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,16295,0)
 ;;=365.11^^105^1016^5
 ;;^UTILITY(U,$J,358.3,16295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16295,1,3,0)
 ;;=3^365.11
 ;;^UTILITY(U,$J,358.3,16295,1,4,0)
 ;;=4^GLAUCOMA,PRIMARY OPEN ANGLE
 ;;^UTILITY(U,$J,358.3,16295,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,16296,0)
 ;;=372.72^^105^1016^11
 ;;^UTILITY(U,$J,358.3,16296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16296,1,3,0)
 ;;=3^372.72
 ;;^UTILITY(U,$J,358.3,16296,1,4,0)
 ;;=4^SUBCONJUNCTIVAL HEMORRHAGE
 ;;^UTILITY(U,$J,358.3,16296,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,16297,0)
 ;;=365.70^^105^1016^1
 ;;^UTILITY(U,$J,358.3,16297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16297,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,16297,1,4,0)
 ;;=4^GLAUCOMA STAGE NOS
 ;;^UTILITY(U,$J,358.3,16297,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,16298,0)
 ;;=365.71^^105^1016^3
 ;;^UTILITY(U,$J,358.3,16298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16298,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,16298,1,4,0)
 ;;=4^GLAUCOMA,MILD STAGE
 ;;^UTILITY(U,$J,358.3,16298,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,16299,0)
 ;;=365.72^^105^1016^4
 ;;^UTILITY(U,$J,358.3,16299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16299,1,3,0)
 ;;=3^365.72
 ;;^UTILITY(U,$J,358.3,16299,1,4,0)
 ;;=4^GLAUCOMA,MODERATE STAGE
 ;;^UTILITY(U,$J,358.3,16299,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,16300,0)
 ;;=365.73^^105^1016^6
 ;;^UTILITY(U,$J,358.3,16300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16300,1,3,0)
 ;;=3^365.73
 ;;^UTILITY(U,$J,358.3,16300,1,4,0)
 ;;=4^GLAUCOMA,SEVERE STAGE
 ;;^UTILITY(U,$J,358.3,16300,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,16301,0)
 ;;=365.74^^105^1016^2
 ;;^UTILITY(U,$J,358.3,16301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16301,1,3,0)
 ;;=3^365.74
 ;;^UTILITY(U,$J,358.3,16301,1,4,0)
 ;;=4^GLAUCOMA,INDETERM STAGE
 ;;^UTILITY(U,$J,358.3,16301,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,16302,0)
 ;;=461.9^^105^1016^10
 ;;^UTILITY(U,$J,358.3,16302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16302,1,3,0)
 ;;=3^461.9
 ;;^UTILITY(U,$J,358.3,16302,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,16302,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,16303,0)
 ;;=571.5^^105^1017^1
 ;;^UTILITY(U,$J,358.3,16303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16303,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,16303,1,4,0)
 ;;=4^CIRRHOSIS OF LIVER
 ;;^UTILITY(U,$J,358.3,16303,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,16304,0)
 ;;=530.81^^105^1017^2
 ;;^UTILITY(U,$J,358.3,16304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16304,1,3,0)
 ;;=3^530.81
 ;;^UTILITY(U,$J,358.3,16304,1,4,0)
 ;;=4^ESOPHAGEAL REFLUX (GERD)
 ;;^UTILITY(U,$J,358.3,16304,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,16305,0)
 ;;=558.9^^105^1017^4
 ;;^UTILITY(U,$J,358.3,16305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16305,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,16305,1,4,0)
 ;;=4^GASTROENTERITIS/COLITIS, NONINFECT
